Lincoln National Corporation (NYSE:LNC)
Lincoln National Corporation (NYSE:LNC) represented a move of 0.77 percent or $-0.68 per share and closed its previous day trading session at $62.97. 1.94 Million Shares were traded in the last trading session with an Average Volume of 1.66 Million Shares. The stock currently has a Market Capitalization of 13.35 Billion.
Lincoln National Corp. is a holding company. Through subsidiary companies, the company operates multiple insurance and investment management businesses. Operations are divided into four business segments: Life Insurance and Annuities; Lincoln UK; Reinsurance and; Investment Management.
The stock traded between $57.06 and $86.68 over 1-Year time period showing its price to sales ratio of 0.86. Lincoln National Corporation (NYSE:LNC) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-2.47 and 200-Day Simple Moving Average of $-7.14. Its Price to Free Cash Flow is 14.32 and Price to Book of 0.9.
Analyst’s recommended the stock as 2.2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Lincoln National Corporation (NYSE:LNC) reported its Actual EPS of $2.34/share. The analysts offering Earnings Estimates for the company were believing that Lincoln National Corporation could bring EPS of $2.17/share. The difference between Actual EPS and Estimated EPS was 0.17 Percent. Thus showing an Earnings Surprise of 7.8 Percent.
Chemours Company (The) (NYSE:CC)
In the last trading session, Chemours Company (The) (NYSE:CC) added its value by -0.07% closing at the price of $28.48. The stock currently has market capitalization of 4.88 Billion, with average volume of 1.87 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Chemours Company (The) (NYSE:CC) is showing beta of 2.57. This particular value of beta suggests that Chemours Company (The) (NYSE:CC) has historically moved 257% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Chemours Company (The) (NYSE:CC) is at $5.96.
The stock currently has RSI of 29.48. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Chemours Company is involved in chemical business. It operating segment consists of Titanium Technologies, Fluoroproducts and Chemical Solutions. Titanium Technologies segment produces titanium dioxide and premium white pigment. Fluoroproducts segment provides fluoroproducts, refrigerants and industrial fluoropolymer resins. Chemical Solutions segment provides industrial and specialty chemicals. The company’s brand consists of Teflon(R), Ti-Pure(R), Krytox(R) Viton(R), Opteon(R) and Nafion(R). Chemours Company is headquartered in Wilmington.
Chemours Company (The) (NYSE:CC) topped its 52-week high price of $54.62 on 01/22/18 and 52-Week Low Price of $27.04 on 11/28/18. The Stock currently has P/E (price to earnings ttm) of 4.78 and Weekly volatility of 4.16% and monthly volatility of 4.57% respectively.